FPEN-button-committee
FPEN-button-committee
FPEN-button-committee
FPEN-button-committee
FPEN-button-committee
FPEN-button-committee
FPEN-button-committee
FPEN-button-committee
FPEN-button-committee
The Daisy Study is investigating the safety, efficacy, and tolerability of Pregabalin as an "add-on" treatment for infants who are between 1 month old and less than 4 years old, with partial onset seizures. To read more about the details of the Daisy Study please click HERE.

If you would like more information about this clinical research study, please contact one of the individuals below:

  • Denise Hubert, Study Administrator, Pediatric Neurology, PA (7485 Sand Lake Commons Blvd., Orlando, FL 32819) at (407) 293-1122, ext. 226
  • Mayra Ferreira, Study Administrator, Pediatric Epilepsy & Neurology Associates (508 S Habana Ave., Tampa, FL 33609) at (813) 873-7367.
*Sponsored*